Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MCY.NZ Stock Summary
In the News
MCY.NZ Financial details
Company Rating
Buy
Market Cap
9.43B
Income
213.5M
Revenue
5.05B
Book val./share
3.46
Cash/share
0.06
Dividend
0.22
Dividend %
3.33%
Employees
1.51K
Optionable
No
Shortable
Yes
Earnings
20 Feb 2024
P/E
19.08
Forward P/E
33
PEG
-3.67
P/S
4.29
P/B
1.88
P/C
115.5
P/FCF
-79.93
Quick Ratio
0.42
Current Ratio
0.79
Debt / Equity
0.42
LT Debt / Equity
0.33
-
-
EPS (TTM)
0.16
EPS next Y
0.21
EPS next Q
-
EPS this Y
-78.12%
EPS next Y
27.42%
EPS next 5Y
-
EPS last 5Y
-22.14%
Revenue last 5Y
6.88%
Revenue Q/Q
12.16%
EPS Q/Q
-241.92%
-
-
-
-
SMA20
-1.02%
SMA50
3.65%
SMA100
16.18%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
10%
ROC
0.07%
Gross Margin
37%
Oper. Margin
27%
Profit Margin
22%
Payout
49%
Shs Outstand
1.39B
Shs Float
674.29M
-
-
-
-
Target Price
-
52W Range
5.665-7.25
52W High
-1%
52W Low
+38.6%
RSI
53.56
Rel Volume
1.07
Avg Volume
558.98K
Volume
595.92K
Perf Week
2.82%
Perf Month
2.67%
Perf Quarter
12.32%
Perf Half Y
11.59%
-
-
-
-
Beta
0.473
-
-
Volatility
0.07%, 0.12%
Prev Close
3.28%
Price
6.93
Change
1.91%
MCY.NZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.44 | 1.27 | 1.47 | 1.55 | 1.97 | |
Net income per share | 0.26 | 0.15 | 0.1 | 0.34 | 0.07 | |
Operating cash flow per share | 0.24 | 0.26 | 0.29 | 0.26 | 0.42 | |
Free cash flow per share | 0.15 | 0.1 | 0.07 | 0.18 | 0.21 | |
Cash per share | 0.07 | 0.1 | 0.13 | 0.07 | 0.06 | |
Book value per share | 2.6 | 2.75 | 3.08 | 3.48 | 3.5 | |
Tangible book value per share | 2.54 | 2.69 | 3 | 3.39 | 3.4 | |
Share holders equity per share | 2.6 | 2.75 | 3.08 | 3.48 | 3.5 | |
Interest debt per share | 0.96 | 0.99 | 1.13 | 1.48 | 1.44 | |
Market cap | 6.26B | 6.4B | 9.08B | 7.72B | 9B | |
Enterprise value | 7.4B | 7.61B | 10.41B | 9.61B | 10.83B | |
P/E ratio | 17.54 | 30.9 | 64.39 | 16.46 | 87.41 | |
Price to sales ratio | 3.2 | 3.69 | 4.53 | 3.64 | 3.3 | |
POCF ratio | 18.91 | 17.97 | 22.76 | 21.33 | 15.42 | |
PFCF ratio | 29.95 | 48.1 | 99.78 | 31.13 | 31.37 | |
P/B Ratio | 1.77 | 1.71 | 2.17 | 1.62 | 1.86 | |
PTB ratio | 1.77 | 1.71 | 2.17 | 1.62 | 1.86 | |
EV to sales | 3.78 | 4.39 | 5.19 | 4.53 | 3.97 | |
Enterprise value over EBITDA | 10.42 | 14.8 | 23.28 | 11.14 | 16.86 | |
EV to operating cash flow | 22.35 | 21.37 | 26.08 | 26.55 | 18.54 | |
EV to free cash flow | 35.4 | 57.21 | 114.37 | 38.76 | 37.72 | |
Earnings yield | 0.06 | 0.03 | 0.02 | 0.06 | 0.01 | |
Free cash flow yield | 0.03 | 0.02 | 0.01 | 0.03 | 0.03 | |
Debt to equity | 0.35 | 0.35 | 0.36 | 0.41 | 0.39 | |
Debt to assets | 0.19 | 0.19 | 0.19 | 0.2 | 0.2 | |
Net debt to EBITDA | 1.6 | 2.36 | 2.97 | 2.19 | 2.84 | |
Current ratio | 0.52 | 0.54 | 0.83 | 0.79 | 0.88 | |
Interest coverage | 6.66 | 5.77 | 4.26 | 9.36 | 2.89 | |
Income quality | 0.93 | 1.7 | 2.83 | 0.77 | 5.67 | |
Dividend Yield | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | |
Payout ratio | 0.58 | 1.03 | 1.57 | 0.49 | 2.5 | |
Sales general and administrative to revenue | 0.04 | 0.05 | 0.04 | 0.04 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.37 | -0.63 | -0.77 | -0.31 | -0.51 | |
Capex to revenue | -0.06 | -0.13 | -0.15 | -0.05 | -0.11 | |
Capex to depreciation | -0.6 | -1.08 | -1.39 | -0.39 | -0.86 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.92 | 3.07 | 2.68 | 5.18 | 2.42 | |
ROIC | 0.09 | 0.05 | 0.03 | 0.08 | 0.03 | |
Return on tangible assets | 0.06 | 0.03 | 0.02 | 0.05 | 0.01 | |
Graham Net | -1.95 | -2.07 | -2.47 | -3.23 | -2.98 | |
Working capital | -395M | -402M | -182M | -271M | -113M | |
Tangible asset value | 3.45B | 3.66B | 4.08B | 4.63B | 4.71B | |
Net current asset value | -2.52B | -2.67B | -2.92B | -3.91B | -3.73B | |
Invested capital | 0.35 | 0.35 | 0.36 | 0.41 | 0.39 | |
Average receivables | 232M | 240M | 270.5M | 388M | 440M | |
Average payables | 207M | 248M | 299M | 359M | 372M | |
Average inventory | 29M | 22.5M | 23M | 59M | 92.5M | |
Days sales outstanding | 46.07 | 49.05 | 56.04 | 80.5 | 55.08 | |
Days payables outstanding | 62.42 | 98.46 | 86.11 | 109.86 | 80.8 | |
Days of inventory on hand | 6.65 | 7.74 | 6.5 | 25.82 | 21.37 | |
Receivables turnover | 7.92 | 7.44 | 6.51 | 4.53 | 6.63 | |
Payables turnover | 5.85 | 3.71 | 4.24 | 3.32 | 4.52 | |
Inventory turnover | 54.91 | 47.18 | 56.17 | 14.14 | 17.08 | |
ROE | 0.1 | 0.06 | 0.03 | 0.1 | 0.02 | |
Capex per share | -0.09 | -0.16 | -0.23 | -0.08 | -0.21 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.48 | 0.94 | 0.51 | 1.03 | 1.16 | |
Net income per share | 0.08 | 0.17 | -0.05 | -0.09 | 0.13 | |
Operating cash flow per share | 0.13 | 0.25 | 0.08 | 0.17 | 0.21 | |
Free cash flow per share | 0.1 | 0.18 | 0.02 | 0.02 | 0.1 | |
Cash per share | 0.04 | 0.04 | 0.06 | 0.06 | 0.06 | |
Book value per share | 3.53 | 3.47 | 3.44 | 3.5 | 3.46 | |
Tangible book value per share | 3.42 | 3.35 | 3.37 | 3.4 | 3.46 | |
Share holders equity per share | 3.53 | 3.47 | 3.44 | 3.5 | 3.46 | |
Interest debt per share | 0.91 | 1.34 | 1.07 | 1.41 | 1.5 | |
Market cap | 7.76B | 7.71B | 8.89B | 9.01B | 9.17B | |
Enterprise value | 8.94B | 9.47B | 10.32B | 10.84B | 11.11B | |
P/E ratio | 16.86 | 8.38 | -35.01 | -17.74 | 13.17 | |
Price to sales ratio | 11.94 | 5.93 | 12.43 | 6.3 | 5.71 | |
POCF ratio | 44.97 | 22.34 | 76.33 | 37.71 | 32.17 | |
PFCF ratio | 57.46 | 30.22 | 306.65 | 281.68 | 65.95 | |
P/B Ratio | 1.61 | 1.6 | 1.83 | 1.86 | 1.91 | |
PTB ratio | 1.61 | 1.6 | 1.83 | 1.86 | 1.91 | |
EV to sales | 13.76 | 7.29 | 14.43 | 7.57 | 6.92 | |
Enterprise value over EBITDA | 39.64 | 20.99 | 60.38 | 28.59 | 28.4 | |
EV to operating cash flow | 51.82 | 27.44 | 88.63 | 45.34 | 38.97 | |
EV to free cash flow | 66.22 | 37.13 | 356.03 | 338.65 | 79.89 | |
Earnings yield | 0.01 | 0.03 | -0.01 | -0.01 | 0.02 | |
Free cash flow yield | 0.02 | 0.03 | 0 | 0 | 0.02 | |
Debt to equity | 0.26 | 0.38 | 0.31 | 0.39 | 0.42 | |
Debt to assets | 0.13 | 0.19 | 0.16 | 0.2 | 0.21 | |
Net debt to EBITDA | 5.24 | 3.9 | 8.37 | 4.81 | 4.96 | |
Current ratio | 0.83 | 0.83 | 0.88 | 0.88 | 0.92 | |
Interest coverage | 0 | 6.17 | 0 | 3.7 | 3.23 | |
Income quality | 1.5 | 1.5 | -1.83 | -1.88 | 1.64 | |
Dividend Yield | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.62 | 0.62 | -0.91 | -0.91 | 0.9 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -0.22 | -0.26 | -0.75 | -0.87 | -0.51 | |
Capex to revenue | -0.06 | -0.07 | -0.12 | -0.14 | -0.09 | |
Capex to depreciation | -0.47 | -0.56 | -1.12 | -1.13 | -0.82 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.59 | 3.6 | 1.87 | 2.68 | 3.12 | |
ROIC | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | |
Return on tangible assets | 0.01 | 0.02 | -0.01 | -0.01 | 0.02 | |
Graham Net | -3.23 | -3.17 | -2.9 | -2.98 | -3 | |
Working capital | -190M | -190M | -113M | -113M | -85M | |
Tangible asset value | 4.65B | 4.65B | 4.75B | 4.71B | 4.8B | |
Net current asset value | -3.89B | -3.89B | -3.73B | -3.73B | -3.69B | |
Invested capital | 0.26 | 0.38 | 0.31 | 0.39 | 0.42 | |
Average receivables | 445M | 422M | 447M | 442M | 0 | |
Average payables | 200M | 151.5M | 151.5M | 172M | 0 | |
Average inventory | 107.5M | 121M | 106M | 91M | 0 | |
Days sales outstanding | 58.48 | 29.24 | 59.37 | 25.91 | 30.17 | |
Days payables outstanding | 0 | 29.64 | 0 | 27.5 | 25.64 | |
Days of inventory on hand | 25.68 | 11.84 | 15.57 | 7.27 | 10.13 | |
Receivables turnover | 1.54 | 3.08 | 1.52 | 3.47 | 2.98 | |
Payables turnover | 0 | 3.04 | 0 | 3.27 | 3.51 | |
Inventory turnover | 3.5 | 7.6 | 5.78 | 12.37 | 8.88 | |
ROE | 0.02 | 0.05 | -0.01 | -0.03 | 0.04 | |
Capex per share | -0.03 | -0.06 | -0.06 | -0.15 | -0.11 |
MCY.NZ Frequently Asked Questions
What is Mercury NZ Limited stock symbol ?
Mercury NZ Limited is a NZ stock and trading under the symbol MCY.NZ
What is Mercury NZ Limited stock quote today ?
Mercury NZ Limited stock price is $6.93 today.
Is Mercury NZ Limited stock public?
Yes, Mercury NZ Limited is a publicly traded company.